Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma

被引:47
作者
Hilvering, Bart [1 ,2 ]
Hinks, Timothy S. C. [1 ,2 ,3 ]
Stoger, Linda [1 ,2 ]
Marchi, Emanuele [4 ,5 ]
Salimi, Maryam [6 ]
Shrimanker, Rahul [1 ,2 ]
Liu, Wei [1 ,2 ]
Chen, Wentao [1 ,2 ]
Luo, Jian [1 ,2 ]
Go, Simei [1 ,2 ]
Powell, Timothy [1 ,2 ]
Cane, Jennifer [1 ,2 ]
Thulborn, Samantha [1 ,2 ]
Kurioka, Ayako [4 ,5 ]
Leng, Tianqi [4 ,5 ]
Matthews, Jamie [4 ,5 ]
Connolly, Clare [1 ,2 ]
Borg, Catherine [1 ,2 ]
Bafadhel, Mona [1 ,2 ]
Willberg, Christian B. [4 ,5 ]
Ramasamy, Adaikalavan [7 ]
Djukanovic, Ratko [3 ,8 ]
Ogg, Graham [6 ]
Pavord, Ian D. [1 ,2 ]
Klenerman, Paul [4 ,5 ]
Xue, Luzheng [1 ,2 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Resp Med Unit, Oxford, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford Biomed Res Ctr, Oxford, England
[3] Univ Southampton, Fac Med, Southampton Univ Hosp, Clin & Expt Sci, Southampton, Hants, England
[4] Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, South Parks Rd, Oxford, England
[5] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg,South Parks Rd, Oxford, England
[6] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England
[7] Univ Oxford, Jenner Inst, Transcript Core Facil, Oxford, England
[8] Southampton Univ Hosp, NIHR Southampton Resp Biomed Res Unit, Southampton, Hants, England
基金
英国惠康基金;
关键词
PLACEBO-CONTROLLED TRIAL; INNATE LYMPHOID-CELLS; HUMAN TH2 CELLS; PROSTAGLANDIN D-2; AIRWAY HYPERRESPONSIVENESS; CYTOKINE PRODUCTION; NASAL POLYPS; DOUBLE-BLIND; EXPRESSION; CRTH2;
D O I
10.1038/s41385-018-0049-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human type-2 CD8(+) T cells are a cell population with potentially important roles in allergic disease. We investigated this in the context of severe asthma with persistent airway eosinophilia-a phenotype associated with high exacerbation risk and responsiveness to type-2 cytokine-targeted therapies. In two independent cohorts we show that, in contrast to Th2 cells, type-2 cytokine-secreting CD8(+)CRTH2(+) (Tc2) cells are enriched in blood and airways in severe eosinophilic asthma. Concentrations of prostaglandin D-2 (PGD2) and cysteinyl leukotriene E-4 (LTE4) are also increased in the airways of the same group of patients. In vitro PGD(2) and LTE4 function synergistically to trigger Tc2 cell recruitment and activation in a TCR-independent manner. These lipids regulate diverse genes in Tc2 cells inducing type-2 cytokines and many other pro-inflammatory cytokines and chemokines, which could contribute to eosinophilia. These findings are consistent with an important innate-like role for human Tc2 cells in severe eosinophilic asthma and suggest a potential target for therapeutic intervention in this and other diseases.
引用
收藏
页码:1408 / 1419
页数:12
相关论文
共 54 条
[51]   Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells [J].
Xue, Luzheng ;
Salimi, Maryam ;
Panse, Isabel ;
Mjosberg, Jenny M. ;
McKenzie, Andrew N. J. ;
Spits, Hergen ;
Klenerman, Paul ;
Ogg, Graham .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (04) :1184-+
[52]   Leukotriene E4 Activates Human Th2 Cells for Exaggerated Proinflammatory Cytokine Production in Response to Prostaglandin D2 [J].
Xue, Luzheng ;
Barrow, Anna ;
Fleming, Vicki M. ;
Hunter, Michael G. ;
Ogg, Graham ;
Klenerman, Paul ;
Pettipher, Roy .
JOURNAL OF IMMUNOLOGY, 2012, 188 (02) :694-702
[53]   Novel Function of CRTH2 in Preventing Apoptosis of Human Th2 Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway [J].
Xue, Luzheng ;
Barrow, Anna ;
Pettipher, Roy .
JOURNAL OF IMMUNOLOGY, 2009, 182 (12) :7580-7586
[54]   Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells [J].
Xue, LZ ;
Gyles, SL ;
Wettey, FR ;
Gazi, L ;
Townsend, E ;
Hunter, MG ;
Pettipher, R .
JOURNAL OF IMMUNOLOGY, 2005, 175 (10) :6531-6536